Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.43%285.18M | -13.13%502.31M | -6.67%251.42M | 15.34%578.22M | 1.16%269.38M | -27.82%501.31M | -28.82%266.29M | -51.86%694.56M | -65.97%374.12M | 114.11%1.44B |
| Operating income | 13.43%285.18M | -13.13%502.31M | -6.67%251.42M | 15.34%578.22M | 1.16%269.38M | -27.82%501.31M | -28.82%266.29M | -51.86%694.56M | -65.97%374.12M | 114.11%1.44B |
| Cost of sales | -13.75%-219.74M | 17.93%-375.28M | 8.86%-193.18M | -16.21%-457.3M | 3.97%-211.97M | 35.14%-393.51M | 32.89%-220.72M | 52.68%-606.74M | 66.55%-328.92M | -129.03%-1.28B |
| Operating expenses | -13.75%-219.74M | 17.93%-375.28M | 8.86%-193.18M | -16.21%-457.3M | 3.97%-211.97M | 35.14%-393.51M | 32.89%-220.72M | 52.68%-606.74M | 66.55%-328.92M | -129.03%-1.28B |
| Gross profit | 12.35%65.44M | 5.04%127.02M | 1.44%58.24M | 12.18%120.93M | 26.00%57.42M | 22.75%107.8M | 0.82%45.57M | -45.32%87.82M | -61.07%45.2M | 40.85%160.6M |
| Selling expenses | -2.29%-3.98M | 8.63%-7.61M | 8.78%-3.89M | 5.21%-8.33M | 2.36%-4.26M | -6.52%-8.79M | -5.03%-4.37M | 0.46%-8.25M | -1.34%-4.16M | 4.98%-8.29M |
| Administrative expenses | -12.73%-70.24M | -0.74%-99.34M | -19.87%-62.31M | 42.06%-98.61M | 40.91%-51.98M | -47.71%-170.21M | -56.82%-87.97M | 2.01%-115.23M | -11.12%-56.1M | 17.64%-117.6M |
| Revaluation surplus | -13.54%89.22M | -7.24%207.13M | -12.07%103.2M | -25.24%223.3M | -16.75%117.36M | 121.66%298.7M | 34.46%140.98M | 49.81%134.76M | 26.23%104.85M | -35.21%89.95M |
| -Changes in the fair value of investment property | -13.54%89.22M | -7.24%207.13M | -12.07%103.2M | -25.24%223.3M | -16.75%117.36M | 121.66%298.7M | 34.46%140.98M | 49.81%134.76M | 26.23%104.85M | -35.21%89.95M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -35.33%-48.75M | 5.19%-74.85M | 14.19%-36.02M | 31.56%-78.95M |
| Special items of operating profit | -51.52%18.74M | 116.39%79.78M | 212.93%38.66M | 433.39%36.87M | 173.48%12.36M | 70.13%-11.06M | 65.92%-16.81M | -164.54%-37.03M | -2,901.36%-49.33M | -10.86%57.37M |
| Operating profit | -25.93%99.19M | 11.97%306.97M | 2.30%133.91M | 26.66%274.15M | 356.78%130.89M | 1,792.96%216.44M | 544.53%28.66M | -112.40%-12.78M | -95.74%4.45M | 104.73%103.08M |
| Financing cost | 32.08%-71.95M | 5.13%-202.35M | -0.37%-105.93M | -52.07%-213.3M | ---105.55M | ---140.27M | ---- | ---- | ---- | ---- |
| Share of profits of associates | -222,450.00%-4.45M | 31.97%-4.14K | 50.00%-2K | 90.97%-6.09K | 84.62%-4K | -365.50%-67.41K | -100.00%-26K | 162.87%25.39K | 7.14%-13K | 35.26%-40.38K |
| Share of profit from joint venture company | 71.91%-2.17M | -64.93%-30.69M | 3.75%-7.71M | -75.39%-18.61M | -71.99%-8.01M | -110.96%-10.61M | -107.86%-4.66M | 818.74%96.83M | 1,730.34%59.26M | -118.34%-13.47M |
| Earning before tax | 1.75%20.62M | 75.02%73.93M | 16.88%20.26M | -35.50%42.24M | -27.68%17.34M | -22.09%65.5M | -62.36%23.97M | -6.13%84.07M | -36.76%63.7M | -27.62%89.56M |
| Tax | 174.79%2.94M | 1,753.84%19.96M | -63.55%1.07M | 92.75%-1.21M | 210.08%2.94M | -331.17%-16.65M | -531.18%-2.67M | -72.94%7.2M | 102.75%619K | 1,001.80%26.62M |
| After-tax profit from continuing operations | 10.44%23.56M | 128.82%93.9M | 5.23%21.34M | -15.98%41.04M | -4.83%20.28M | -46.49%48.84M | -66.87%21.31M | -21.44%91.28M | -17.79%64.32M | -3.81%116.19M |
| Earning after tax | 10.44%23.56M | 128.82%93.9M | 5.23%21.34M | -15.98%41.04M | -4.83%20.28M | -46.49%48.84M | -66.87%21.31M | -21.44%91.28M | -17.79%64.32M | -3.81%116.19M |
| Minority profit | ---- | ---- | ---- | -280.43%-96.9K | 232.00%33K | 67.75%-25.47K | 35.90%-25K | -3.50%-78.99K | -21.88%-39K | -96.70%-76.31K |
| Profit attributable to shareholders | 10.44%23.56M | 128.28%93.9M | 5.40%21.34M | -15.83%41.13M | -5.10%20.24M | -46.51%48.87M | -66.86%21.33M | -21.42%91.36M | -17.77%64.35M | -3.78%116.26M |
| Dividend per share | ---- | -58.33%0.005 | ---- | -33.33%0.012 | ---- | -40.00%0.018 | ---- | 0.00%0.03 | ---- | 0.00%0.03 |
| Basic earnings per share | 10.30%0.0257 | 128.89%0.103 | 5.91%0.0233 | -13.46%0.045 | -2.65%0.022 | -45.26%0.052 | -66.02%0.0226 | -19.49%0.095 | -15.72%0.0665 | -1.67%0.118 |
| Diluted earnings per share | 10.30%0.0257 | 128.89%0.103 | 5.91%0.0233 | -13.46%0.045 | -2.65%0.022 | -45.26%0.052 | -66.02%0.0226 | -19.49%0.095 | -15.72%0.0665 | -1.67%0.118 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.